A 38-year-old man with multiple drug dependencies (alcohol, opioids, benzodiazepines) was admitted to a drug withdrawal facility for assisted detoxification. He received buprenorphine for opioid withdrawal management alongside benzodiazepines and other psychotropic medications. Critical clinical errors occurred: nursing staff observed pinpoint pupils indicating opioid intoxication but continued administering buprenorphine. The patient received 20mg buprenorphine over 12 hours (versus recommended 8-12mg for first 24 hours) with inadequate monitoring of emerging sedation on the final day. He died from multidrug toxicity and respiratory depression. Preventable factors included excessive dosing, failure to escalate when pinpoint pupils were noted, lack of response to progressive somnolence, and inadequate physician-nurse communication. The case highlights critical gaps in medication guidelines, nurse education regarding buprenorphine-benzodiazepine interactions, and sedation monitoring during complex withdrawal management.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes.
Excessive buprenorphine dosing (20mg over 12 hours versus recommended 8-12mg for first 24 hours)
Co-administration of buprenorphine with benzodiazepines and other sedating drugs (quetiapine, mirtazapine)
Failure to escalate care when pinpoint pupils indicating opioid intoxication were documented
Inadequate nursing response to progressive somnolence on final day
Lack of increased monitoring despite documented signs of toxicity
Insufficient physician-nurse communication regarding clinical deterioration
Absence of daily face-to-face medical review over weekend
Complex withdrawal management in patient with multiple dependencies and modest opioid tolerance
Discrepancies between facility medication guidelines and contemporary NSW clinical guidelines
Coroner's recommendations
Admit patients with complex needs to Corella Lodge earlier in the week rather than later, to allow maximum medical coverage
Conduct a review by addiction medication specialists of the DHS Medication Guidelines for Inpatient Detoxification in light of NSW Clinical Guidelines: Treatment of Opioid Dependence (2018), including appropriate dosing guidelines, guidance on buprenorphine with other sedating drugs, and clarification of PRN and breakthrough doses
Provide further training for nurses at Corella Lodge on: DHS Medication Guidelines, NSW 2018 Clinical Guidelines, clinical management and monitoring of sedation with benzodiazepine-buprenorphine co-administration, clinical judgment in PRN/breakthrough dosing, and steps when patients are unexpectedly intoxicated
Ensure a copy of the DHS Medication Guidelines for Inpatient Detoxification is available at the Nurses' Station
Introduce a sedation chart to observations for patients receiving buprenorphine and/or benzodiazepines
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. All court orders for redaction and non-publication are respected; documents with technically defective redaction have been excluded from the database entirely. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction —